51
Participants
Start Date
November 4, 2016
Primary Completion Date
March 31, 2017
Study Completion Date
March 31, 2017
Bioscalin® new formulation with Galeopsis Segetum
Total duration of the study was 4 months; each subject, took by mouth two capsules/die of placebo at breakfast and one tablet/die of study product at lunch for the first 3 months of the trial.
Reference product
Total duration of the study was 4 months; each subject, took by mouth two capsules/die of reference product at breakfast and one tablet/die of placebo at lunch for the first 3 months of the trial.
Placebo
Total duration of the study was 4 months; each subject, took by mouth two capsules/die of placebo at breakfast and one tablet/die of placebo at lunch for the first 3 months of the trial.
Lead Sponsor
Derming SRL
OTHER